Страна: Армения
Язык: английский
Источник: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում
deproteinised haemoderivate of calf blood
“Takeda Pharmaceuticals” LLC
առկա չէ (B06AB)
deproteinised haemoderivate of calf blood
40mg/ml
solution for injection
(5/1x5/) ampoules 5ml, in blister
Prescription
Registered
2020-12-30
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT ACTOVEGIN® 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each ampoule 2 ml contains Actovegin concentrate as an active ingredient (based on anhydrous deproteinized calf blood derivative) 1) – 80 mg; _excipients: _water for injection up to 2 ml. Each ampoule 5 ml contains Actovegin concentrate as an active ingredient (based on anhydrous deproteinized calf blood derivative) 1) – 200 mg; _excipients: _water for injection up to 5 ml. Each ampoule 10 ml contains Actovegin concentrate as an active ingredient (based on anhydrous deproteinized calf blood derivative) 1) – 400 mg; _excipients:_ water for injection up to 10 ml. 1) Actovegin ® concentrate contains sodium and chloride ions, which are the components of calf blood. Sodium Chloride is not added or removed during the concentrate manufacturing process. Quantity of Sodium Chloride is about 53,6 mg (for ampoule 2 ml), about 134,0 mg (for ampoule 5 ml) and about 268,0 mg (for ampoule 10 ml). 3. PHARMACEUTICAL FORM Solution for injection Description: Clear yellowish solution 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS As part of combined therapy: Symptomatic treatment of cognitive impairment including post-stroke cognitive impairment and dementia; Symptomatic treatment of peripheral perfusion disorders and their sequelae; Symptomatic treatment of diabetic polyneuropathy (DPN). 4.2 POSOLOGY AND METHOD OF ADMINISTRATION For intra-arterial, intravenous, intramuscular administration, and may also be added to infusion solutions. Directions for use of one-point-cut ampoules: Hold the ampoule with the colored dot facing up. Make sure to remove all the liquid from the top of the ampoule by gently shaking and tapping it with a finger. Hold the ampoule with the colored dot facing up. Snap the ampoule tip as shown in the picture. Corresponding to the severity of the clinical picture, initially 10-20 ml i.v. or i.a. daily; for further treatment, 5 ml i.v. or slowly i.m. daily or several Прочитать полный документ